HOME >> BIOLOGY >> NEWS
New Northwestern center targets brain disorders

combining molecular biology and gene discovery with the pragmatism of engineering in order to solve this problem and others."

The second potential therapy is based on the discovery by Moskal and colleagues of a family of molecules called glyxins that appear to enhance learning and memory. The Food and Drug Administration recently approved the glyxins for human phase I trials.

"The glyxins also may have an impact on attention deficit hyperactivity disorder, memory loss associated with the early stages of Alzheimer's disease as well as normal aging, damage due to stroke, and neuropathic pain," said Moskal. He has collaborated for years with John Disterhoft, professor of physiology at Feinberg, in evaluating the compounds.

Recently, another long-time collaborator, Jaak Panksepp, an emeritus professor in the psychology department at Bowling Green State University, joined the Falk Center as head of its affective neuroscience research program.

The Falk Center puts state-of-the-art gene chip technology -- the same used to discover the glyxins and the brain tumor therapy -- into the hands of Northwestern faculty and students. This technology, used to identify gene targets for new therapeutics, is more often found in the private sector than in universities.

"Very few universities in the country have direct access to gene chip technology of this caliber," said Roger Kroes, chief of molecular neuro-oncology at Falk and assistant research professor of biomedical engineering. "In the Chicago area, only a handful of programs in academia and the private sector combined have facilities equivalent to the Falk Center's."

Moskal and his staff build their own microarrays from scratch and are continually evolving the technology. Now they can train faculty, undergraduate and graduate students, and visiting scholars to build customized gene chips for their own discoveries. Moskal and his staff already have taught a class in advanced mo
'"/>

Contact: Megan Fellman
fellman@northwestern.edu
847-491-3115
Northwestern University
10-Feb-2003


Page: 1 2 3

Related biology news :

1. Northwesterns Cancer Genetics Program pinpoints gene that increases cancer risk by 26 percent
2. Northwestern receives $5.65 million for reproductive research
3. Northwestern launches major gene banking project
4. A little larceny comes naturally to Northwestern crows
5. Northwestern receives $17 million for functional genomics research
6. Northwestern program aims at revealing genetic causes of spina bifida
7. Northwestern researchers map gene mutation that makes mice deaf and causes them to dance
8. Northwestern scientists shed new light on neurodegenerative diseases
9. Northwestern researchers clone gene responsible for inner ear motor
10. Northwestern team identifies first enzyme in mammalian circadian clock
11. Northwestern Hosts Public Forum On Future Of Biotechnology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... , Jan. 25, 2016   Unisys Corporation (NYSE: ... at John F. Kennedy (JFK) International Airport, New York ... (CBP) identify imposters attempting to enter the United ... belong to them. pilot testing of the system ... at three terminals at JFK during January 2016. --> ...
(Date:1/21/2016)... 21, 2016 --> ... market research report "Emotion Detection and Recognition Market by Technology ... (Facial Expression, Voice Recognition and Others), Services, Application ... to 2020", published by MarketsandMarkets, the global Emotion ... USD 22.65 Billion by 2020, at a CAGR ...
Breaking Biology News(10 mins):
(Date:2/8/2016)... FLINT, Mich. , Feb. 8, 2016  Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that ... as a specialty pharmacy resource–user-centric, story-driven, knowledge-based and mobile-friendly. ... ... ... "The ...
(Date:2/5/2016)...  In the pharmaceutical industry the medical affairs function ... activities including the identification and engagement of key thought ... high in the oncology therapeutic area where most treating ... Role of Medical Affairs in Oncology Launch Excellence ." ... find better ways to utilize medical affairs to develop ...
(Date:2/4/2016)... -- - New FDA action date of July ... date of July 22, 2016   --> ... 2016   - Lifitegrast has the potential ... the treatment of signs and symptoms of dry eye disease in ... be the only product approved in the U.S. in the past decade indicated for the ...
(Date:2/4/2016)... N.J. , Feb. 4, 2016  CytoSorbents ... immunotherapy leader commercializing its flagship CytoSorb® blood filter ... surgery patients around the world, announced that CEO ... present at the Source Capital Group,s 2016 Disruptive ... update on the company.  Conference ...
Breaking Biology Technology:
Cached News: